NanoLogix, Inc. (NNLX)

Market Cap	16.29K
Revenue (ttm)	1.27K
Net Income (ttm)	-1.95M
Shares Out	162.89M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,000
Average Volume	98,973
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0000 - 0.0401
Beta	-49.00
RSI	60.52
Earnings Date	n/a

About NanoLogix

NanoLogix, Inc., a biotechnology company, provides live cell and rapid diagnostics test kits that detects viable bacteria and other microorganisms. The company’s products include BioNanoPore kit, which employs a water permeable membrane that works with organic and inorganic molecules, as well as proteins; and FlatPack Petri Plates that are used for the isolation and cultivation of various fastidious and non-fastidious microorganisms, as well as displays growth of aerobic and anaerobic microorganisms. Its products are used in medical, national d...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Bret Barnhizer
• Employees: 7
• Stock Exchange: OTCMKTS
• Ticker Symbol: NNLX

Financial Performance

In 2011, NanoLogix's revenue was $892, an increase of 39.38% compared to the previous year's $640. Losses were -$1.86 million, -29.93% less than in 2010.